Corticosteroid-induced osteoporosis in adults;L'osteoporose cortisonique de l'adulte

Presse Medicale

Volumn 27, Issue 32, 1998, Pages 1641-1646

  Weryha, G ^a,c   Klein, M ^a   Guillemin, F ^b,c   Leclere J ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c GESO Est ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM DERIVATIVE; CORTICOSTEROID; VITAMIN D DERIVATIVE; GLUCOCORTICOID;

ADULT; BONE ATROPHY; CORTICOSTEROID THERAPY; DRUG INDUCED DISEASE; HORMONE SUBSTITUTION; HUMAN; OSTEOPOROSIS; PROPHYLAXIS; REVIEW; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; PATHOPHYSIOLOGY;

ADULT; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; OSTEOPOROSIS;

EID: 0032564120     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Verhoeven AC, Boers M. Limited bone loss due to corticosteroids ; a systematic review of prospective studies in rheumatoid arthritis and other diseases. J Rheumatol 1997 ; 24:1495-503.
2. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations. Bull John Hopkins Hosp 1932 ; 50:137-95.
3. Adachi JD, Bensen WG, Brown J et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997 ; 337:382-7.
4. Saag KG, Emkey R, Schnitzer TJ et al. Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. N Engl J Med 1998 ; 339:292-9.
5. Roux C, Oriente P, Laan R et al. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group. J Clin Endocrinol Metab 1998 ; 83:1128-33.
6. Compston JE, Audran M, Avouac B et al. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines. Arthritis Rheum 1996 ; 39:1791-801.
7. Weryha C, Leclere J. Paracrine regulation of bone remodeling. Horm Res 1995 ; 43:69-75.
8. Delany AM, Dong Y, Canalis E. Mechanisms of glucocorticoid action in bone cells. J Cell Biochem 1994 ; 56:295-302.
9. Caniggia A, Nuti R, Lore F, Vattimo A. Pathophysiology of the adverse effects of glucoactive corticosteroids on calcium metabolism in man. J Steroid Biochem 1981 ; 15:153-61.
10. Adler RA, Rosen G. Glucocorticoids and osteoporosis. Endocrinol Metab Clin North Am 1994 ; 23:641-54.
11. Birkenhager JC, Heul Rvd, Smeenk D, Sluys VJvd, Seters Av. Bone changes associated with glucocorticoid excess. Proc R Soc Med 1967 ; 60:1134-6.
12. Condon JR, Nassim JR, Dent CE, Hilb A, Stainthorpe EM. Possible prevention and treatment of steroid-induced osteoporosis. Postgrad Med J 1978 ; 54:249-52.
13. Gennari C. Differential effect of glucocorticoids on calcium absorption and bone mass. Br J Rheumatol 1993 ; 2:11-4.
14. Godschalk MF, Downs RW. Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Miner Res 1988 ; 3:113-5.
15. Morris HA, Need AG, O'Loughlin PD, Horowitz M, Bridges A, Nordin BEC. Malabsorption of calcium in corticosteroid-induced osteoporosis. Calcif Tissue Int 1990 ; 46:305-8.
16. Weinstein RS, Jilka RL, Michael Parfitt A, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998 ; 102:274-82.
17. Swolin D, Brantsing C, Matejka G, Ohlsson C. Cortisol decreases IGF-I mRNA levels in human osteoblast-like cells. J Endocrinol 1996 ; 149:397-403.
18. Hakeda Y, Kawaguchi H, Hurley M et al. Intact insulin-like growth factor binding protein-5 (IGFBP-5) associates with bone matrix and the soluble fragments of IGFBP-5 accumulated in culture medium of neonatal mouse calvariae by parathyroid hormone and prostaglandin E2-treatment. J Cell Physiol 1996 ; 166:370-9.
19. Chappard D, Legrand E, Basle MF et al. Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study. J Bone Miner Res 1996 ; 11:676-85.
20. Manning PJ, Evans MC, Reid IR. Normal bone mineral density following cure of Cushing's syndrome. Clin Endocrinol (Oxf) 1992 ; 36:229-34.
21. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990 ; 112:352-64.
22. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983 ; 309:265-8.
23. LoCascio V, Bonucci E, Imbimbo B et al. Bone loss in response to long-term glucocorticoid therapy. Bone Miner 1990; 8:39-51.
24. van Schaardenburg D, Valkema R, Dijkmans BA et al. Prednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatment. Arthritis Rheum 1995 ; 38:334-42.
25. Laan RF, van Riel PL, van de Putte LB, van Erning LJ, van't Hof MA, Lemmens JA. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Ann Intern Med 1993 ; 119:963-8.
26. Lufkin EG, Wahner HW, Bergstralh EJ. Reversibility of steroid-induced osteoporosis. Am J Med 1988 ; 85:887-8.
27. Catargi B, Tabarin A, Basse-Cathalinat B, Ducassou D, Roger P. Development of bone mineral density after cure of Cushing's syndrome. Ann Endocrinol (Paris) 1996 ; 57:203-8.
28. Dobnig H, Stepan V, Leb C, Wolf G, Buchfelder M, Krejs GJ. Recovery from severe osteoporosis following cure from ectopic ACTH syndrome caused by an appendix carcinoid. J Intern Med 1996 ; 239:365-9.
29. Michel BA, Bloch DA, Wolfe F, Fries JF. Fractures in rheumatoid arthritis:an evaluation of associated risk factors. J Rheumatol 1993 ; 20:1666-9.
30. Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994 ; 344:23-7.
31. Gluck O, Murphy W, Hahn T, Hahn B. Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy. Arthritis Rheum 1985; 24:892-8.
32. Nilsen KH, Jayson MI, Dixon AS. Microcrystalline calcium hydroxyapatite compound in corticosteroid-treated rheumatoid patients:a controlled study. Br Med J 1978; 2:1124.
33. Sambrook P, Birmingham J, Kelly P et al. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 1993 ; 328:1747-52.
34. Reid IR, King AR, Alexander Q, Ibbertson HK. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet 1988 ; i:143-6.
35. Hahn TJ, Hahn BH. Osteopenia in patients with rheumatic diseases: principles of diagnosis and therapy. Semin Arthritis Rheum 1976 ; 6:165-88.
36. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH. Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. J Clin Invest 1979 ; 64:655-65.
37. Gonnelli S, Rottoli P, Cepollaro C et al. Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients. Calcif Tissue Int 1997 ; 61:382-5.
38. Lems WF, Jacobs WC, Bijlsma JW et al. Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis. Osteoporos Int 1997 ; 7:575-82.
39. Greenwald M, Brandli D, Spector S, Silverman S, Golde G. Corticosteroid-induced osteoporosis: effects of a treatment with slow-release sodium fluoride. Osteoporos Int 1992 ; 2:303-4.
40. Adachi JD, Bensen WG, Bell MJ et al. Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis. Scand J Gastroenterol 1997 ; 32:255-9.
41. Healey JH, Paget SA, Williams-Russo P et al. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica. Calcif Tissue Int 1996 ; 58:73-80.
42. Lukert BP, Johnson BE, Robinson RG. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 1992 ; 7:1063-9.
43. Sambrook P, Birmingham J, Champion D et al. Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens. J Rheumatol 1992 ; 19:357-61.
44. Hall GM, Daniels M, Doyle DV, Spector TD. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum 1994 ; 37:1499-505.